gm27 is a deletion that removes approximately nine predicted genes on the left arm of the X chromosome. One of these genes is the nuclear receptor
fax-1 (see abstracts by Carmean et al. and Wightman et al.).
gm27 homozygous animals are phenotypically very similar to animals that are homozygous for a point mutation in the
fax-1 gene (
gm83).
gm27 homozygotes do not appear more severely affected than
fax-1(
gm83) homozygotes, other than a reduction in brood size. This suggests that deletion of the genes flanking
fax-1 results in a relatively subtle effect on the animal. Among the flanking genes that are deleted by
gm27 is one that encodes a predicted RalGDS (F28B4.2), a guanine nucleotide-exchange factor for Ral G proteins. Biochemical studies in vertebrates and C. elegans (K. Kariya, personal communication) have demonstrated that RalGDS binds to activated ras protein. Therefore, RalGDS has been proposed to be a mediator of ras signaling.
gm27 homozygotes do not display defects in vulval or male tail development, indicating that deletion of this RalGDS alone does not affect ras signaling significantly. We considered the possibility that the F28B4.2 RalGDS could have a modulatory effect on ras signaling. We created
gm27; ras(gf) double mutants to determine if deletion of RalGDS enhances or suppresses ras mutations.
gm27; ras(gf) double mutants displayed a fully-penetrant Muv defect, unlike ras(gf) alone. Moreover, approximately 20% of double mutants arrested during late larval or early adult stages and displayed a clear phenotype. These phenotypes are similar to those observed when activated ras is overexpressed. Therefore, deletion of this region of the X chromosome appears to enhance activated ras.
fax-1(
gm83); ras(gf) double mutants are similar to ras(gf) alone, indicating the enhancement of activated ras is not due to deletion of
fax-1. We are currently testing whether this enhancement is dependent on deletion of RalGDS, another gene, or a combination of genes. If the enhancement is due to deletion of RalGDS, this would suggest that, counter to the commonly-accepted model, RalGDS functions as a negative modulator of ras signaling. We also tested the possibility that deletion of RalGDS could have effects on mutations in genes that function in other signal transduction pathways. The
gm27 deletion did not obviously enhance
mig-2(
gm103) or
unc-73 (
e936). However,
gm27 mig-2(
gm38) double mutants displayed an increase in the penetrance of the withered-tail phenotype associated with
mig-2 and significant lethality. Therefore,
gm27 may also enhance gain-of-function mutations that perturb Rho family signaling. This raises the possibility that the F28B4.2 RalGDS may be a negative modulator of two signal transduction pathways.